Photothermal Ablation of Cancer Cells by Albumin-Modified Gold Nanorods and Activation of Dendritic Cells.
Xiuhui WangJingchao LiNaoki KawazoeGuoping ChenPublished in: Materials (Basel, Switzerland) (2018)
Nanoparticle-mediated photothermal therapy has been widely studied for cancer treatment. It is important to disclose how photothermally ablated tumor cells trigger immune responses. In this study, bovine serum albumin (BSA)-coated gold nanorods (BSA-coated AuNRs) were prepared and used for photothermal ablation of breast tumor cells. The BSA-coated AuNRs showed high photothermal conversion efficiency and good photothermal ablation effect towards tumor cells. The ablated tumor cells were co-cultured with immature dendritic cells (DCs) through a direct cell contacting model and diffusion model to confirm the stimulatory effects of cell⁻cell interaction and soluble factors released from ablated tumor cells. The results indicated that photothermally ablated tumor cells induced immune-stimulatory responses of DCs through both cell⁻cell interaction and soluble factors. The results should be useful for synergistic photothermal-immunotherapy of primary and metastatic cancer.
Keyphrases
- dendritic cells
- single cell
- immune response
- cancer therapy
- photodynamic therapy
- cell therapy
- drug delivery
- small cell lung cancer
- drug release
- squamous cell carcinoma
- stem cells
- gold nanoparticles
- toll like receptor
- radiofrequency ablation
- papillary thyroid
- reduced graphene oxide
- silver nanoparticles
- childhood cancer
- lymph node metastasis